Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Simo Sääskilahti, CFO of Neles, appointed Neles’ interim President and CEO as of January 1, 2022

Neles Corporation, Stock exchange release, November 30, 2021, at 3:00 p.m. EETNeles’ Board of Directors has appointed CFO Simo Sääskilahti as Neles’ interim President and CEO as of January 1, 2022. The current President and CEO, Olli Isotalo, will continue in the role until December 31, 2021. The merger between Valmet and Neles is planned to take place on or before April 1, 2022, once the necessary merger control approvals by the relevant competition authorities are obtained. In the merged company Neles is planned to be organized as an independent organizational entity called Flow

MilDef wins UK deal with new product

MilDef has won its first significant order with a product for remote controlling of unmanned vehicles and sensor systems. The order consists of 100 tactical tablets and 100 robot controllers. The end customer is specialist users with the UK defence sector. Order value is approximately SEK 7 million.The new product consists of a rugged tablet that is docked with a customizable robot controller. The combination creates an advanced capability to remotely control unmanned vehicles or sensor systems and show sensor data and other information on the display. A powerful processor completes the

Diamyd Medical pauses start of Phase III trial

Diamyd Medical has today decided to pause the start of the precision medicine Phase III trial DIAGNODE-3 as well as the initiation of other clinical trials with the diabetes vaccine Diamyd[®] (GAD/alum) pending additional evaluations of the manufacturing process. A new analysis has shown the potential presence of a contamination early in the manufacturing process of the current study drug and Diamyd Medical will evalaute its specific removal before additional clinical work is conducted.“We take this new information seriously and deem it is most prudent to pause the initiation of pending

Sitowise and Livair join forces

SITOWISE GROUP PLC INVESTOR NEWS 30 NOVEMBER 2021 Sitowise has acquired Livair Oy – a company founded in 1990 and based in Espoo – who provide planning and consulting services related to HPAC engineering. “Livair is a respected company, whose expertise perfectly complements our service offering. We have collaborated on projects before and want to provide a productive growth environment for Livair’s expertise”, says Timo Palonkoski, director of Sitowise’s Buildings business area. Livair has extensive experience in HVAC design and consulting for both new and renovation building sites,

Change in number of shares outstanding in Sectra AB during November

Linköping, Sweden – November 30, 2021 – During November, the number of shares outstanding in the medical imaging IT and cybersecurity company Sectra  (STO: SECT B) decreased by 13,103,460 Class A redemption shares and 179,524,010 Class B redemption shares. As of November 30, 2021, the number of shares totals 192,627,470.The change is attributable to Sectra’s 2021 share redemption program. Read more at investor.sectra.com/redemption2021.   The number of shares after the change is distributed as follows: · 13,103,460 ordinary Class A shares · 179,524,

Q3 report 2021 – interview with Crunchfish CEO Joachim Samuelsson

Today, Crunchfish AB (“Crunchfish”) published its interim report for Q3 and the first nine months 2021. CEO Joachim Samuelsson has been interviewed by Västra Hamnen Corporate Finance around Digital Cash and Gesture Interaction as well as the company’s current projects and prospects.Listen to the interview with Alf Riple at Västra Hamnen Corporate Finance here:https://www.youtube.com/watch?v=el5odM4FRkg For more information, please contact:Joachim Samuelsson, CEO of Crunchfish AB+46 708 46 47 88joachim.samuelsson@crunchfish.com  Erik Berggren, IR Manager+46 726 01 16 73erik.

Dometic Capital Markets Update 2021

At the Dometic Capital Markets Update on November 30, 2021 President and CEO, Juan Vargues, will together with Management team members share insights from the company’s strategy execution and on how the current Outdoor market trends create opportunities for continued growth and margin expansion.Juan Vargues, President and CEO says: “Market trends and the cross over between traditional recreational vehicles and passenger vehicles, like SUVs, drive a need for innovative, flexible and energy-efficient end-user solutions. With our leadership in technology, strong market presence and broad

BioStock: RhoVac gives guidance on new indications for RV001

While testing its candidate RV001 in prostate cancer patients in a phase IIb trial, Lund-based RhoVac is making plans to out-licensing the project. To set the stage for a possible deal, comprehensive market research has been conducted to provide guidance on the medical need for a cancer relapse vaccine in additional cancer indications. Overall, the company concludes that there is great need for a vaccine that prevents tumour recurrence and highlights two cancer indications as particularly interesting.Read the full article at biostock.se:https://www.biostock.se/en/2021/11/rhovac-gives-

Updated agenda for Stora Aktiedagen on December 1 at 10.30 now including review of new diagnostic data

On Wednesday December 1 at 10.30, Attana will participate in Aktiespararna’s Stora Aktiedag where Attana’s CEO, Teodor Aastrup, will give a 20-minute-long presentation followed by a 10-minute-long Q&A.The content of the presentation has been updated from the previously communicated agenda and will now also include a review of initial data generated from the study carried out by Attana in collaboration with the Linnaeus University and Region Kalmar. In the ongoing study, patient samples are tested both before and after vaccination against different variants of the SARS-CoV-2 virus (Alpha

Audientes expands distribution network to rural India through new partnership

Audientes A/S and Challa’s Hearing Care Centre & Speech Therapy Centre, India, today announce a Supply Framework Agreement for the sale of Audientes’ self-fitting hearing aid, Ven™, in Challa’s clinic in Hyderabad and its 20 additional associated clinics throughout the states of Telangana and Andhra Pradesh.Audientes has entered into another supply framework agreement in India. Today’s announcement of a Supply Framework Agreement with Challa’s Hearing Care Centre & Speech Therapy Centre, Hyderabad, and its associated 20 clinics throughout Telangana and Andhra Pradesh in Eastern India means

Change in number of shares and votes in BONESUPPORT Holding AB (publ)

Lund, Sweden, 12:00 CET, 30 November 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votes. During November, the number of shares and votes in BONESUPPORT Holding AB (publ) has increased with 10,000 due to the exercise of warrants.   As of 30 November 2021, the number of shares in BONESUPPORT HOLDING AB (publ) amounts to 65,451,672 shares, of which 64,161,672 are ordinary shares with one vote per share and 1,290,000 are series C-shares with one-tenth of a vote per share.

Change in number of shares and votes in Indutrade AB (publ)

The incentive programme for senior executives and key employees implemented at the Annual General Meeting held on 26 April 2017 has resulted in an increase in the number of shares and votes in the company during November 2021 by 86,400 shares and votes, through the exercise of warrants entitling to subscription for new shares in the company. As of 30 November 2021, there are in total 364,188,000 shares and votes in the company. Stockholm on 30 November 2021 INDUTRADE AB (publ) For further information, please contactPatrik Johnson, CFOPhone: +46 8 703 03 00, +46 70 397 50 30

Alfa Laval Capital Markets Day 2021

Today, November 30, Alfa Laval hosted its 2021 Capital Markets Day as a streamed digital event. The focus was on the company’s ongoing transformation journey, driven by its extended offering within sustainability and digitalization to support further organic growth.Over the last couple of years Alfa Laval has delivered strong growth in its existing businesses and is well positioned to continue supporting customers as they accelerate the shift towards improved energy efficiency and sustainable operations. To support Alfa Laval’s continued expansion, the company has initiated an investment

Catena Media announces outcome of warrants exercised post-Q3 2021 report subscription period

Catena Media plc (“Catena Media” or the “company”) today announces the outcome of the subscription period following the publication of the interim report for the third quarter of 2021 (“subscription period”) of the warrants 2020/2024 (“warrants”) issued as part of the rights issue of units. Exercise of warrants A total of 609,984 warrants, corresponding to approximately 1.8 percent of all outstanding warrants (being approximately 1.3 percent of all warrants issued as part of the rights issue), were used to subscribe for the same number of new ordinary shares in the company. The

Sitowise Group Plc issues 10,490 own shares in a directed issue

Sitowise Group Plc, Stock Exchange Release 30 November 2021 at 12:50 pm (EET) Sitowise Group Plc issues 10,490 own shares in a directed issue On 29 November 2021, the Board of Directors of Sitowise Group Plc ("Sitowise") has decided, by virtue of the authorisation granted by the unanimous resolution of the shareholders on 3 March 2021, to issue in a directed issue 10,490 own Sitowise shares (the "Shares"), that the Board of Directors of Sitowise issued to the company itself on 29 June 2021. The number of Shares to be subscribed for in the share issue (the "Share Issue") corresponds to

Brand new Quick Analysis is a game changer for Netigate customers

Netigate, one of Europe’s leading providers of feedback management, has expanded its offering with intelligent new reporting functionality. An extension of the existing Netigate report function, Quick Analysis allows users to get instant insights into their customer and employee feedback data.Quick Analysis  is the newest innovation in a period of rapid growth and development for Netigate. Following a rebranding and comprehensive platform update last year,

Change in the number of shares and votes in AFRY

As of 30 November 2021, the number of shares in AFRY AB (publ) ("AFRY") amounts to 113,207,940, divided into 4,290,336 class A shares with ten votes each and 108,917,604 class B shares with one vote each. The total number of votes amounts to 151,820,964. During November, convertibles issued in AFRY's 2018 convertible programme have been converted to 7,047 class B shares. Further, the reduction of the share capital through cancellation of 700,681 own class B shares as resolved by the 2021 Annual General Meeting has been executed through registration with the Swedish Companies Registration

Viking Line Abp publishes prospectus relating to its rights offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR FURTHER INFORMATION, PLEASE SEE THE “IMPORTANT NOTICE” BELOW.Viking Line Abp   STOCK EXCHANGE RELEASE  30.11. 2021 AT 12.30 pm EEST Viking Line Abp publishes prospectus relating to its rights offering The Finnish Financial

Erik Ekman Appointed New CEO in Bluefish

ERIK EKMAN IS APPOINTED NEW CEO FOR BLUEFISH PHARMACEUTICALS AB Erik Ekman becomes the new CEO of Bluefish Pharmaceuticals. Erik will take up the position of CEO during the spring 2022 since Berit Lindholm has announced to the Board that she is leaving Bluefish Pharmaceuticals joining a non-competitive organisation. Erik Ekman holds the COO position in the company since the last four years. Erik has a solid experience in the pharmaceutical industry and has previously held various roles in both AstraZeneca and Cambrex. Erik is a passionate and experienced leader who will be able to

CTEK shortlisted for Company and Brand of the Year in Dalarna Business Star Awards

Vikmanshyttan-based CTEK, the leading global brand in vehicle charging solutions, is delighted to have been shortlisted for two awards - Company of the Year and Brand of the Year - in the Dalarna Business ’Star Awards’ 2021.CTEK is one of four businesses shortlisted for Company of the Year, and four businesses listed for Brand of the Year, in these prestigious awards, which are presented to entrepreneurs and companies that have excelled in one way or another, recognising the dedicated employees who have worked purposefully to develop their companies. The nominees have been selected by

Eficode positioned as a Leader in the ISG Provider Lens™ Report on Public Cloud – Solutions & Services

Eficode is recognized by ISG for its “extensive domain, technological and cultural expertise”Helsinki, Finland, 30 November 2021 -- Eficode, Europe’s leading DevOps company, has been recognized by ISG (Information Services Group), a leading global technology research and advisory firm, as a Leader for Public Cloud – Services & Solutions in the Nordic region , in their 2021 ISG Provider Lens™ Quadrant  report. The ISG Provider Lens™ report assists organizations with the evaluation of public cloud transformation solutions and service

Read original

Nordisk Bergteknik acquires BGS Svensson – further strengthens the offering and market position in region Västra Götaland

Nordisk Bergteknik has today signed an agreement regarding the acquisition of all shares in BGS Svensson AB, an established foundation solutions company based in Kungshamn. Through the acquisition, Nordisk Bergteknik continues to strengthen its offering and presence in region Västra Götaland, with the ambition to serve as a strategic partner in selected niches in the market for construction and contracting services within infrastructure.BGS Svensson was founded in 2008 and is expected, for the full year of 2021, to reach a turnover of SEK 90–100 million with a solid profitability that will

The Board of Directors of NoHo Partners Plc has resolved to extend the duration of the long-term share-based incentive plan for the key employees and on the third earning period of the long-term incentive plan

NoHo Partners Plc STOCK EXCHANGE RELEASE 30 November 2021 at 11:45The Board of Directors of NoHo Partners Plc has resolved to extend the duration of the long-term share-based incentive plan for the key employees and on the third earning period of the long-term incentive planNoHo Partners Plc's Board of Directors has resolved to amend the terms of the long-term incentive plan for the company's key employees due to the changes in the company’s business environment caused by the Covid-19 pandemic. The terms of the long-term incentive plan will be amended by extending the duration of the

Interim report for the third quarter of 2021:

Year-to-date revenue up 8 %, pipeline still growing, particularly within Vertical FarmingToday, LED iBond International’s (LED iBond) Board of Directors approved the interim report for the third quarter (Q3) of 2021. Highlights of the report include: Business development · Overall, new business opportunities are continually identified and validated, in particular within vertical farming, where the sales pipeline is constantly growing, and the first installations have been successfully delivered. However, the COVID-19 pandemic and the global shortage of electronic components are

There are no items matching the current filter
There are no more items matching the current filter
Back to top